Downloadable Resource Hemophilia Gene Therapy Resource Guide Gene therapy will become a powerful approach in the management of hemophilia and could offer a definitive cure. Our resource guide explores ongoing clinical trial results and emerging data.
|
Newsletter New and Emerging Therapies for Relapsed/Refractory Follicular Lymphoma Loretta J. Nastoupil, MD; Catherine S. Diefenbach, MD
|
Webinar Replay Latest Advances in Gene Therapy for Hemophilia Steven W. Pipe, MD
|
Newsletter Frontline Treatment of DLBCL: Practice Implications Andrew D. Zelenetz, MD, PhD
|
Newsletter Treating Relapsed/Refractory DLBCL: Practice Implications Matthew Lunning, DO, FACP
|
Newsletter Diagnosis and Management of Pediatric and Adult Patients with Immune Thrombocytopenia Hanny Al-Samkari, MD and Michele P. Lambert, MD, MSTR
|
Newsletter Addressing Disparities in Care for Patients with DLBCL Loretta J. Nastoupil, MD
|
CE Education Faculty Roundtable on CAR T-cell Therapies, Bispecific Antibodies & Antibody-Drug Conjugates in FL Loretta J. Nastoupil, MD and Catherine S. Diefenbach, MD
|
CE Education Selecting Optimal Therapy for Patients with Hemophilia Meera B. Chitlur, MD
|
CE Education Improving Outcomes for Pediatric and Adult Patients with Immune Thrombocytopenia Hanny Al-Samkari, MD and Michele P. Lambert, MD, MSTR
|
Newsletter Key Facts in Diagnosing and Managing VWD Angela C. Weyand, MD
|
Newsletter Diagnosing and Managing Pediatric and Young Adult Patients Living with VWD Sarah O'Brien, MD
|
CE Education Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma James O. Armitage, MD; John P. Leonard, MD; and Jason Westin, MD, MS, FACP
|
Newsletter Prophylaxis as a New Strategy for the Management of Patients with VWD Miguel A. Escobar, MD
|
CE Education New Directions in the Frontline Treatment of DLBCL: Implications for Practice James O. Armitage, MD; and Andrew D. Zelenetz, MD, PhD
|
CE Education New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice James O. Armitage, MD; and Matthew Lunning, DO, FACP
|
Newsletter Recognizing and Treating von Willebrand's Disease in Women Miguel A. Escobar, MD
|
CE Education Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice James O. Armitage, MD; and Gilles Salles, MD, PhD
|
CE Education Prophylaxis in Patients with Von Willebrand Disease: Expert Perspectives and Shared Experiences Robert F. Sidonio, Jr., MD, Miguel A. Escobar, MD, Angela C. Weyand, MD
|
CE Education Addressing Disparities in Care for Patients with DLBCL James O. Armitage, MD; and Loretta J. Nastoupil, MD |